E

Escient Pharmaceuticals

39 employees

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$120M

from 16 investors over 16 rounds

E

Escient Pharmaceuticals raised $120M on November 28, 2022

Investors: Osage University Partners (OUP), Redmile Group, The Column Group, Sanofi Ventures, Avego Healthcare Capital, The Eleven Fund and Partner Fund Management

E

Escient Pharmaceuticals raised $78M on September 14, 2020

Investors: Osage University Partners (OUP), Sanofi Ventures, Perceptive Advisors, Redmile Group, The Column Group and 5AM Ventures

E

Escient Pharmaceuticals raised $40M on May 9, 2018

Investors: 5AM Ventures, Osage University Partners (OUP) and The Column Group

FAQ